Carcinogenesis 41:27 Haroun RA-H, Osman WH, Amin RE, Hassan AK, Abo-Shanab WS, Eessa AM (2022) Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection
E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2312 - ESOC25-2352 MAPPING THE MODIFIED RANKIN SCALE (MRS) INTO THE 5-LEVEL EQ-5D (EQ-5D-5L) IN ISCHEMIC STROKE PATIENTS Florentina Pinckaers 1 , Janneke Grutters 2 , Silvia Evers 3 , Hester Lingsma 4 , Jeroen Boogaarts 5 , Diederik Dippel 6 , Linda Jacobi-Postma 1 , Aad van der Lugt 7 , Charles Majoie 8 , Yvo Roos 9 , Robert van Oostenbrugge 10 , Wim Van Zwam 1 , Andrea Gabrio 11 1 Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, Netherlands, 2 Department for Health Evidence, Radboud UMC, Nijmegen, Netherlands, 3 Department of Health Services Research, Maastricht University, Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands, 4 Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands, 5 Department of Neurosurgery, Radboud UMC, Nijmegen, Netherlands, 6 Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 7 Department of Radiology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 8 Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, Netherlands, 9 Department of Neurology, Amsterdam UMC, Amsterdam, Netherlands, 10 Department of Neurology, Maastricht University Medical Centre+, Maastricht, Netherlands, 11 Department of Methodology and Statistics, Maastricht University, Maastricht, Netherlands Background and Aims: To translate the modified Rankin Score (mRS) at three months after ischemic stroke into EQ-5D-5L utility values, which may be used for the derivation of quality-adjusted life years for cost-effectiveness analyses
2020c), Egr-1/miR-15a-5p/GPX4/ferroptosis signaling pathway (Fan et al
Ubivist LC Tablet Ubivist LC Tablet Product Images Other information Content details Last updated on 23 Jul 2026 | 01:03 AM (IST) Manufacturer details Name: A)AllPiLL Biotech Address: A)Plot no
doi: 10.1038/s41467-017-01965-8 58 SeoJJeongDWParkJWLeeKWFukudaJChunYS
What are the main side effects and risks
